Abstract 036 Infarct size expressed as a percentage of the risk zone (I/R%)

Treatment groupControlIPC one cycleIPC three cycles
Values represent mean (SEM).
n>6 per group.
*p<0.05 compared to control.
12 weeks control38.4 (5.1)%33.1 (4.7)%27.1 (3.5)%*
12 weeks glimepiride43.9 (1.4)%31.9 (3.8)%*33.5 (2.4)%*
24 h control42.3 (2.8)%43.0 (4.7)%26.0 (5.9)%*
24 h glimepride42.2 (2.3)%31.1 (3.0)%*29.3 (3.3)%*
Acute control42.6 (5.3)%36.8 (4.5)%28.6 (6.0)%*
Acute glimepiride41.9. (5.4)%28.2 (3.7)%*24.6 (5.4)%*